<SEC-DOCUMENT>0000950123-11-061759.txt : 20110627
<SEC-HEADER>0000950123-11-061759.hdr.sgml : 20110627
<ACCEPTANCE-DATETIME>20110627070831
ACCESSION NUMBER:		0000950123-11-061759
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110627
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110627
DATE AS OF CHANGE:		20110627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HANMI FINANCIAL CORP
		CENTRAL INDEX KEY:			0001109242
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		IRS NUMBER:				954788120
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30421
		FILM NUMBER:		11931835

	BUSINESS ADDRESS:	
		STREET 1:		3660 WILSHIRE BLVD SUITE PH-A
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90010
		BUSINESS PHONE:		2133822200
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v59803e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of The Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><!-- xbrl,dc --><B>June&nbsp;27, 2011<BR>
Date of Report (date of earliest event reported)</B><!-- /xbrl,dc --></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>HANMI FINANCIAL CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>(exact names of registrant as specified in its charter)</B></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Commission File Number</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>95-4788120</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>(state or other jurisdiction of</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>000-30421</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>(I.R.S. Employer Identification Number)</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>incorporation or organization)</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>3660 Wilshire Boulevard, Ph-A<BR>
Los Angeles, California 90010<BR>
(Address of principal executive offices, including zip code)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>(213)&nbsp;382-2200<BR>
(Registrant&#146;s telephone number, including area code)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Not Applicable<BR>
(Former name or former address, if changed since last report)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT style="font-family: Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!--TOC-->
<!--/TOC-->




<!-- link1 "Item&nbsp;1.01. Entry into a Material Definitive Agreement" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;1.01. Entry into a Material Definitive Agreement.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;27, 2011, Hanmi Financial Corporation (the &#147;Company&#148;) entered into a Common Stock
Purchase Agreement (the &#147;Agreement&#148;) with Woori Investment &#038; Securities (&#147;Woori&#148;) pursuant to which
Woori agreed to purchase in a private placement transaction that number of shares equal to 4.9
percent of the Company&#146;s outstanding common stock immediately after the closing of the Company&#146;s
previously announced public offering, subject to adjustment in certain circumstances, at a price
per share equal to the public offering price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The private placement is contingent upon the closing of the Company&#146;s public offering. The
announcement of the public offering was previously reported in the Company&#146;s Current Report on Form
8-K filed with the Securities and Exchange Commission on June&nbsp;20, 2011.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company made certain customary representations and warranties to Woori in the Agreement
concerning the Company, its business and the shares of common stock to be issued in the private
placement. In addition, the parties agreed to enter into a registration rights agreement
containing customary terms and provisions for the resale registration of the shares to be sold to
Woori. The registration rights agreement will provide (i)&nbsp;a covenant by the Company to file the
resale registration statement within 45 calendar days following the receipt by the Company of a
notice from Woori exercising its registration right in the case of any registration eligible to
be made on Form S-3 or comparable form, or within 60 calendar days following the receipt of such
notice by the Company in the case of any registration made on Form S-1 or comparable form; and (ii)
a covenant by the Company to use its commercially reasonable efforts to cause the registration
statement to be declared effective by the SEC as soon as practicable. The foregoing description of
the Agreement is qualified in its entirety by reference to such agreement, a copy of which is filed
as Exhibit&nbsp;10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
</DIV>
<!-- link1 "Item&nbsp;3.02. Unregistered Sales of Equity Securities" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3.02. Unregistered Sales of Equity Securities.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent required by Item&nbsp;3.02 of Form 8-K, the information contained in Item&nbsp;1.01 of
this Form 8-K regarding the private placement transaction between the Company and Woori is
incorporated by reference in this Item&nbsp;3.02. The private placement transaction has been conducted
in reliance upon the exemption from registration provided for by Section&nbsp;4(2) of the Securities Act
of 1933, as amended.
</DIV>
<!-- link1 "Item&nbsp;8.01. Other Events" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8.01. Other Events.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;27, 2011, the Company issued a press release announcing the private placement
transaction with Woori. A copy of the press release is attached hereto as Exhibit&nbsp;99.1 and is
incorporated herein by reference.
</DIV>
<!-- link1 "Item&nbsp;9.01. Financial Statements and Exhibits" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01. Financial Statements and Exhibits.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(d)&nbsp;Exhibits.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Number</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">10.1</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">Common Stock Purchase Agreement, dated June&nbsp;27, 2011, by and
between Hanmi Financial Corporation and Woori Investment &#038;
Securities.</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">99.1</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">Press release dated June&nbsp;27, 2011</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "SIGNATURE" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>HANMI FINANCIAL CORPORATION</B><BR>
(Registrant)<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">June 27, 2011&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ <FONT style="FONT-variant: SMALL-CAPS">Jay S. Yoo</FONT>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Jay S. Yoo&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "INDEX TO EXHIBITS" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Number</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">10.1</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">Common Stock Purchase Agreement, dated June&nbsp;27, 2011, by and
between Hanmi Financial Corporation and Woori Investment &#038;
Securities.</DIV></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="right">&nbsp;</TD>
    <TD valign="top" align="right">99.1</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:0px; text-indent:-0px">Press release dated June&nbsp;27, 2011</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v59803exv10w1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;10.1</B><BR>
<BR>
<B>CONFIDENTIAL</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>HANMI FINANCIAL CORPORATION</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Common Stock Purchase Agreement</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">June&nbsp;27, 2011
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WOORI INVESTMENT &#038; SECURITIES<BR>
23-4 Yoido-dong Youngdungpo-gu<BR>
Seoul 150-725 Korea

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hanmi Financial Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), proposes to issue
and sell to you (the &#147;<U>Purchaser</U>&#148;) that number of shares of common stock, par value $0.001
per share (the &#147;<U>Common Stock</U>&#148;), of the Company as determined pursuant to the calculation
set forth in Section 1(a) below (the &#147;<U>Shares</U>&#148;). The issuance and sale to the Purchaser of
the Shares is to be consummated immediately subsequent to the closing of the issuance and sale of
shares of the Company&#146;s Common Stock in its proposed public offering (the &#147;<U>Public
Offering</U>&#148;) pursuant to an Underwriting Agreement to be entered into by and between the Company
and FBR Capital Markets &#038; Co. (the &#147;<U>Underwriter</U>&#148;). Such Underwriting Agreement, in the
form executed by the Company and the Underwriter in connection with the Public Offering, is
referred to herein as the &#147;<U>Underwriting Agreement</U>&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has filed with the Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;), a
registration statement on Form&nbsp;S-3 (No.&nbsp;333-163206) including a prospectus (the &#147;<U>Registration
Statement</U>&#148;), for the registration of the shares to be sold in the Public Offering (the
&#147;<U>Public Offering Shares</U>&#148;) under the Securities Act of 1933, as amended (the &#147;<U>Securities
Act</U>&#148;), and the rules and regulations thereunder (the &#147;<U>Securities Act Regulations</U>&#148;).
The term &#147;<U>Base Prospectus</U>&#148; means the prospectus dated November&nbsp;30, 2009 included in the
Registration Statement, including all information incorporated by reference therein. The term
&#147;<U>Prospectus Supplement</U>&#148; means the final prospectus supplement specifically relating to the
Public Offering Shares in the form first filed with the SEC pursuant to Rule&nbsp;424 under the
Securities Act, including all information incorporated by reference therein. The term
&#147;<U>Prospectus</U>&#148; means the Base Prospectus together with the Prospectus Supplement. The term
&#147;<U>Preliminary Prospectus</U>&#148; means the preliminary form of the Prospectus in the form filed
with the SEC in connection with the Public Offering pursuant to Rule&nbsp;424 of the Securities Act
Regulations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Purchase of the Shares by the Purchaser</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company agrees to issue and sell the Shares to the Purchaser as provided in this
agreement (the &#147;<U>Agreement</U>&#148;), and the Purchaser agrees to purchase from the Company the
Shares at a price per share (the &#147;<U>Purchase Price</U>&#148;) equal to the per share public offering
price in the Public Offering (prior to any underwriting discounts and commissions) (the
&#147;<U>Offering Price</U>&#148;). The number of shares to be sold by the Company and purchased by the
Purchaser shall equal that number of shares equal to 4.9&nbsp;percent of the Company&#146;s issued and
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">outstanding Common Stock (after taking into account the issuance of the shares in the Public
Offering); provided, however, if such share amount shall result in the Purchaser becoming the
single stockholder of record or beneficial owner of the largest amount of the Company&#146;s outstanding
Common Stock at the closing (after taking into account the issuance of the shares in the Public
Offering), then the number of shares to be sold by the Company and purchased by the Purchaser shall
be reduced by a number such that the Purchaser becomes the stockholder of record or beneficial
owner of one (1)&nbsp;share less than the stockholder of the second largest amount of the Company&#146;s
outstanding Common Stock at the closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Payment for the Shares shall be made by wire transfer in immediately available funds to
the account specified by the Company to the Purchaser, at the location and at the time of the
closing of the Public Offering, subject to the satisfaction of the conditions set forth herein. The
time and date of such payment for the Shares is referred to herein as the &#147;<U>Closing Date</U>&#148;.
On the Closing Date, the Company shall deliver to the Purchaser a certificate executed by an
officer of the Company specifying the exact number of shares that are being purchased by the
Purchaser and the purchase price that is being paid therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment for the Shares to be purchased on the Closing Date shall be made against delivery to
the Purchaser of the Shares registered in the name of the Purchaser, which Shares shall be
uncertificated shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Registration Rights</U>.
In connection with the purchase of the Shares, the Purchaser and the Company agree to enter
into a Registration Rights Agreement containing customary terms and provisions for the resale
registration of securities purchased in a private placement (the &#147;<U>Rights Agreement</U>&#148;),
solely for the purpose of providing the Purchaser with registration rights with respect to the
Shares; provided, however, the Rights Agreement shall provide (i)&nbsp;a covenant by the Company to file
the resale registration statement within 45 calendar days following the receipt by the Company of a
notice from Purchaser exercising its registration right (the &#147;<U>Demand Notice</U>&#148;) in the case
of any registration eligible to made on Form S-3 or comparable form, or within 60 calendar days
following the receipt of the Demand Notice by the Company in the case of any registration made on
Form S-1 or comparable form; and (ii)&nbsp;a covenant by the Company to use its commercially reasonable
efforts to cause the registration statement to be declared effective by the SEC as soon as
practicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Representations and Warranties of the Company</U>.
The Company hereby represents and warrants to the Purchaser as of the date hereof and as of
the Closing Date (except for the representations and warranties that specify that they are made as
of the date that the Underwriting Agreement is entered into by the Company and the Underwriter (the
&#147;<U>UA Execution Date</U>&#148;) and as of the Closing Date, which shall be made as of the UA Execution
Date and as of the Closing Date):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Organization and Qualification</U>. The Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the State of Delaware, with
power and authority (corporate and other) to own its properties and conduct its business as now
conducted, and has been duly qualified as a foreign corporation for the transaction of business and
is in good standing under the laws of each jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification, except where the failure
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to so qualify or be in good standing in any such jurisdiction would not, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect. For purposes of this
Section&nbsp;3, &#147;<U>Material Adverse Effect</U>&#148; means any material adverse change, or any development
involving a prospective material adverse change, (i)&nbsp;in or affecting the general affairs,
management, consolidated financial position, consolidated stockholders&#146; equity or consolidated
results of operations of the Company and its subsidiaries, taken as a whole, or (ii)&nbsp;that could
adversely affect, prevent or delay, in any material respect, the ability of Company to perform any
of its covenants or obligations under this Agreement or the Rights Agreement, or to consummate the
sale and issuance of the Shares or the other transactions contemplated hereby and thereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Authorization; Enforceability</U>. The Company has the requisite corporate power and
authority to enter into this Agreement and the Rights Agreement and to perform its obligations
hereunder and thereunder. All corporate action on the part of the Company, its officers, directors
and stockholders necessary for the authorization, execution and delivery of this Agreement and the
Rights Agreement, the performance of all obligations of the Company hereunder and thereunder, and
the authorization, issuance and delivery of the Shares has been taken and no other corporate
proceedings on the part of the Company, its officers, directors or stockholders are necessary to
authorize and approve this Agreement, the Rights Agreement or the transactions contemplated hereby
and thereby. Each of this Agreement and the Rights Agreement has been duly executed and delivered
by the Company and constitutes (or will constitute at the Closing Date) the valid and legally
binding obligations of the Company, enforceable against the Company in accordance with its terms
(i)&nbsp;except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, and any other laws of general application affecting enforcement of creditors&#146; rights
generally, and as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies, or (ii)&nbsp;to the extent the indemnification provisions contained
in the Rights Agreement may be limited by applicable federal or state securities laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Valid Issuance of Shares</U>. The Shares have been duly authorized and, when issued
and delivered against payment therefor as provided herein, will be validly issued and fully paid
and non-assessable, and as of the UA Execution Date and the Closing Date will conform to the
description of the Company&#146;s Common Stock contained in the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>No Conflicts</U>. The issue and sale of the Shares, the compliance by the Company with
this Agreement and the Rights Agreement and the consummation of the transactions herein and therein
contemplated will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which the Company or any of its subsidiaries is a
party or by which the Company or any of its subsidiaries is bound or to which any of the property
or assets of the Company or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of the
provisions of the Certificate of Incorporation or Bylaws of the Company, each as amended to date,
or (iii)&nbsp;result in any violation of any statute or any order, rule or regulation of any court or
governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any
of their properties, except in the case of (i)&nbsp;and (iii), as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect; and no consent, approval,
authorization, order, registration or qualification of or with any such court or governmental
agency or body is required for the issue and sale of the Shares by the
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company or the consummation by the Company of the transactions contemplated by this Agreement
or the Rights Agreement, except (A)&nbsp;such consents, approvals, authorizations, orders, registrations
or qualifications as may be required under Regulation&nbsp;D of the Securities Act of 1933, as amended
(the &#147;<U>Securities Act</U>&#148;), state securities or Blue Sky laws, or (B)&nbsp;where the failure to
obtain any such consent, approval, authorization, order, registration or qualification would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>No Violation or Default</U>. Neither the Company nor any of its subsidiaries is (i)&nbsp;in
violation of its Certificate of Incorporation or Bylaws, each as amended to date, or (ii)&nbsp;in
default in the performance or observance of any obligation, agreement, covenant or condition
contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or
instrument to which it is a party or by which it or any of its properties may be bound, except in
the case of (ii)&nbsp;for such defaults as would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Description of Capital Stock</U>. As of the UA Execution Date and as of the Closing
Date, the statements set forth in the Prospectus under the caption &#147;Description of Capital Stock&#148;,
insofar as they purport to constitute a summary of the terms of the Company&#146;s capital stock, are
accurate, complete and fair in all material respects.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Broker</U>. The Company has not, and no director, officer or employee of it has,
employed any broker or finder, or incurred or will incur any broker&#146;s, finder&#146;s or similar fees,
commissions or expenses, in each case in connection with the transactions contemplated by this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Registration Statement</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;The Company has prepared and filed the Registration Statement in conformity with the
requirements of the Securities Act and the Securities Act Regulations, which became effective as of
November&nbsp;30, 2009, which provide for the offering of Common Stock and other securities of the
Company, including the offering of the Public Offering Shares, from time to time in accordance with
Rule&nbsp;415(a)(1)(x) of the Securities Act Regulations, and such amendments thereof as may have been
required. The Company and the proposed Public Offering meet the requirements and comply with the
conditions for the use of Form S-3 under the Securities Act. The Company has complied, to the
SEC&#146;s satisfaction, with all requests of the SEC for additional or supplemental information. Any
Rule 462(b) Registration Statement has become effective under the Securities Act. No stop order
suspending the effectiveness of the Registration Statement or any Rule 462(b) Registration
Statement has been issued by the SEC, and no proceedings for that purpose have been instituted or
are pending or, to the Company&#146;s knowledge, are contemplated or threatened by the SEC, and any
request received by the Company on the part of the SEC for additional information has been complied
with.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;The Registration Statement and any Rule 462(b) Registration Statement, as of their
effective dates and as of the date hereof, did not, do not and will not contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading; and the Preliminary
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Prospectus does not, and the Prospectus or any amendment or supplement thereto will not, as of
the applicable filing date, the UA Execution Date and the Closing Date, contain an untrue statement
of a material fact or omit to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading; provided, however, that
the Company makes no warranty or representation with respect to any statement contained in or
omitted from the Registration Statement, the Preliminary Prospectus or the Prospectus in reliance
upon and in conformity with the information concerning the Underwriter and furnished in writing by
or on behalf of the Underwriter through the Underwriter to the Company expressly for use therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Prospectus</U>. The Preliminary Prospectus when filed and the Registration Statement
as of each effective date and as of the UA Execution Date complied or will comply, and the
Prospectus and any further amendments or supplements to the Registration Statement, the Preliminary
Prospectus or the Prospectus will, when they become effective or are filed with the SEC, as the
case may be, comply, in all material respects with the requirements of the Securities Act and the
Securities Act Regulations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <U>Issuer Free Writing Prospectus</U>. The term &#147;<U>Issuer Free Writing Prospectus</U>&#148;
means any issuer free writing prospectus, as defined in Rule&nbsp;433 of the Securities Act Regulations.
The term &#147;<U>Free Writing Prospectus</U>&#148; means any free writing prospectus, as defined in Rule
405 of the Securities Act Regulations. Each Issuer Free Writing Prospectus, if any, as of its
issue date and at all subsequent times through the Closing Date did not, does not and will not
include any information that conflicted, conflicts or will conflict with the information contained
in the Registration Statement. As of its issue date or date of first use and at all subsequent
times through the UA Execution Date, each Issuer Free Writing Prospectus, if any, when considered
together with the rest of the disclosure package used by the Underwriter pursuant to the
Underwriting Agreement (the &#147;<U>Disclosure Package</U>&#148;), did not, and at the time of each sale of
the Public Offering Shares and at the Closing Date, each such Issuer Free Writing Prospectus will
not, contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading; provided, however, that the Company makes no warranty or representation with
respect to any statement contained in or omitted from the Disclosure Package in reliance upon and
in conformity with the information concerning the Underwriter and furnished in writing by the
Underwriter to the Company expressly for use therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <U>Free Writing Prospectuses</U>. The Company is eligible to use Free Writing
Prospectuses in connection with this offering pursuant to Rules&nbsp;164 and 433 under the Securities
Act; any Free Writing Prospectus that the Company is required to file pursuant to Rule 433(d) under
the Securities Act Regulations has been, or will be, filed with the SEC in accordance with the
requirements of the Securities Act and the Securities Act Regulations; and each Free Writing
Prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the
Securities Act Regulations or that was prepared by or on behalf of or used by the Company complies
or will comply in all material respects with the requirements of the Securities Act and the
Securities Act Regulations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Representations and Warranties of the Purchaser</U>.
The Purchaser hereby represents and warrants to the Company as of the date hereof and as of
the Closing Date that:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Organization and Qualification</U>. The Purchaser has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the country of Korea, with
power and authority (corporate and other) to own its properties and conduct its business as now
conducted, and has been duly qualified as a foreign corporation for the transaction of business and
is in good standing under the laws of each jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification, except where the failure to so qualify
or be in good standing in any such jurisdiction would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. For purposes of this Section&nbsp;4,
&#147;<U>Material Adverse Effect</U>&#148; means any material adverse change, or any development involving a
prospective material adverse change, (i)&nbsp;in or affecting the general affairs, management,
consolidated financial position, consolidated stockholders&#146; equity or consolidated results of
operations of the Purchaser and its subsidiaries, taken as a whole, or (ii)&nbsp;that could adversely
affect, prevent or delay, in any material respect, the ability of the Purchaser to perform any of
its covenants or obligations under this Agreement or the Rights Agreement, or to consummate the
purchase of the Shares or the other transactions contemplated hereby and thereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Authorization; Enforceability</U>. The Purchaser has the requisite corporate or other
applicable organizational power and authority to enter into this Agreement and the Rights Agreement
and to perform its obligations hereunder and thereunder. All corporate or other applicable
organizational action on the part of the Purchaser, its officers, directors and stockholders
necessary for the authorization, execution and delivery of this Agreement and the Rights Agreement,
and the performance of all obligations of the Purchaser hereunder and thereunder has been taken and
no other corporate or other applicable organizational proceedings on the part of the Purchaser, its
officers, directors or stockholders are necessary to authorize and approve this Agreement, the
Rights Agreement or the transactions contemplated hereby and thereby. Each of this Agreement and
the Rights Agreement has been duly executed and delivered by the Purchaser and constitutes (or will
constitute at the Closing Date) the valid and legally binding obligations of the Purchaser,
enforceable against the Purchaser in accordance with its terms (i)&nbsp;except as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of
general application affecting enforcement of creditors&#146; rights generally, and as limited by laws
relating to the availability of specific performance, injunctive relief, or other equitable
remedies, or (ii)&nbsp;to the extent the indemnification provisions contained in the Rights Agreement
may be limited by applicable federal or state securities laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>No Conflicts</U>. The purchase of the Shares, the compliance by the Purchaser with
this Agreement and the Rights Agreement and the consummation of the transactions herein and therein
contemplated will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which the Purchaser or any of its subsidiaries is a
party or by which the Purchaser or any of its subsidiaries is bound or to which any of the property
or assets of the Purchaser or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of
the provisions of the corporate charter documents of the Purchaser, or (iii)&nbsp;result in any
violation of any statute or any order, rule or regulation of any court or governmental agency or
body having jurisdiction over the Purchaser or any of its subsidiaries or any of their properties,
except in the case of (i)&nbsp;and (iii), as would not, individually or in the aggregate, reasonably be
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">expected to have a Material Adverse Effect; and no consent, approval, authorization, order,
registration or qualification of or with any such court or governmental agency or body is required
for the purchase of the Shares by the Purchaser or the consummation by the Purchaser of the
transactions contemplated by this Agreement or the Rights Agreement, except where the failure to
obtain any such consent, approval, authorization, order, registration or qualification would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Purchase Entirely for Own Account</U>. The Purchaser hereby confirms that the Shares
will be acquired for investment for the Purchaser&#146;s own account, not as a nominee or agent, and not
with a view to the resale or distribution of any part thereof, and that the Purchaser has no
present intention of selling, granting any participation in, or otherwise distributing the same. By
executing this Agreement, the Purchaser further represents that the Purchaser does not presently
have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant
participations to such person or to any third person, with respect to any of the Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Disclosure of Information</U>. The Purchaser believes it has received all the
information it considers necessary or appropriate for deciding whether to purchase the Shares. The
Purchaser further represents that it has had an opportunity to ask questions and receive answers
from the Company regarding the terms and conditions of the offering of the Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Restricted Securities</U>. The Purchaser understands that the Shares are being issued
in a transaction that was not, and will not be, registered under the Securities Act by reason of a
specific exemption from the registration provisions of the Securities Act which depends upon, among
other things, the bona fide nature of the investment intent and the accuracy of the Purchaser&#146;s
representations as expressed herein. The Purchaser understands that the Shares are &#147;restricted
securities&#148; under applicable U.S. federal and state securities laws and that, pursuant to these
laws, the Purchaser must hold the Shares indefinitely unless they are registered with the SEC and
qualified by state authorities, or an exemption from such registration and qualification
requirements is available. The Purchaser acknowledges that the Company has no obligation to
register or qualify the Shares for resale. The Purchaser further acknowledges that if an exemption
from registration or qualification is available, it may be conditioned on various requirements
including, but not limited to, the time and manner of sale, the holding period for the Shares, and
on requirements relating to the Company which are outside of the Purchaser&#146;s control, and which the
Company is under no obligation and may not be able to satisfy.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Legends</U>. The Purchaser understands that the Shares may bear one or all of the
following legends:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&#147;THE SHARES REPRESENTED BY THIS CERTIFICATE WERE ISSUED IN A TRANSACTION THAT WAS NOT
REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A
VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY
BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN
A FORM REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE
SECURITIES ACT OF 1933.&#148;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Any legend required by the Blue Sky laws of any state to the extent such laws are
applicable to the Shares represented by the certificate so legended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Accredited Investor</U>. The Purchaser is an accredited investor as defined in Rule
501(a) of Regulation&nbsp;D promulgated under the Securities Act. The Purchaser&#146;s principal place of
business is set forth in Section&nbsp;8 below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Broker</U>. The Purchaser has not, and no director, officer or employee of it has,
employed any broker or finder, or incurred or will incur any broker&#146;s, finder&#146;s or similar fees,
commissions or expenses, in each case in connection with the transactions contemplated by this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Conditions of Purchaser&#146;s Obligations</U>.
The obligation of the Purchaser to purchase the Shares on the Closing Date as provided
herein is subject to the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Representations and Warranties</U>. The representations and warranties of the Company
contained herein shall be true and correct on the date hereof and on and as of the Closing Date
(except to the extent any such representations and warranties expressly relate to an earlier date,
in which case, as of such earlier date, and except for the representations and warranties that
specify that they are made as of the UA Execution Date and as of the Closing Date, in which case,
as of the UA Execution Date and as of the Closing Date).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Public Offering Shares</U>. The Underwriter shall have purchased, immediately prior to
the purchase of the Shares by the Purchaser hereunder, the Public Offering Shares at the same
purchase price (less any underwriting discounts or commissions) per share payable by the Purchaser
hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>No Legal Impediment to Issuance</U>. No action shall have been taken and no statute,
rule, regulation or order shall have been enacted, adopted or issued by any federal, state or
foreign governmental or regulatory authority that would, as of the Closing Date, prevent the
issuance or sale of the Shares; and no injunction or order of any federal, state or foreign court
shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the
Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Conditions of Company&#146;s Obligations</U>. The obligation of the Company to issue and sell the Shares on the Closing Date as provided
herein is subject to the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Representations and Warranties</U>. The representations and warranties of the
Purchaser contained herein shall be true and correct on the date hereof and on and as of the
Closing Date (except to the extent any such representations and warranties expressly relate to an
earlier date, in which case, as of such earlier date).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Public Offering Shares</U>. The Underwriter shall have purchased, immediately prior to
the issuance and sale of the Shares by the Company hereunder, the Public Offering Shares at the
same purchase price (less any underwriting discounts or commissions) per share payable by the
Purchaser hereunder.
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>No Legal Impediment to Issuance</U>. No action shall have been taken and no statute,
rule, regulation or order shall have been enacted, adopted or issued by any federal, state or
foreign governmental or regulatory authority that would, as of the Closing Date, prevent the
issuance or sale of the Shares; and no injunction or order of any federal, state or foreign court
shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the
Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Termination</U>. This Agreement shall automatically terminate upon the earliest to occur of (i)&nbsp;the written
consent of each of the Company and the Purchaser, (ii)&nbsp;following the execution of the Underwriting
Agreement, the termination of such Underwriting Agreement in accordance with its terms, or (iii)
July&nbsp;31, 2011, if the closing of the Public Offering has not occurred on or prior to such date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Miscellaneous.</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Confidentiality</U>. The Company and the Purchaser acknowledge that they have
previously executed a non-disclosure agreement dated May&nbsp;17, 2011 (the &#147;<U>Confidentiality
Agreement</U>&#148;), which shall continue in full force and effect in accordance with its terms.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Notices</U>. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form
of telecommunication.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If to the Company:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Hanmi Financial Corporation<BR>
3660 Wilshire Boulevard<BR>
Penthouse Suite&nbsp;A<BR>
Los Angeles, CA 90010<BR>
Fax: (213)&nbsp;639-5617<BR>
Attention: Mark Yoon

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">With a copy to:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Greenberg Traurig, LLP<BR>
2450 Colorado Avenue<BR>
Suite&nbsp;400 East<BR>
Santa Monica, CA 90404<BR>
Fax: (310)&nbsp;586-0556<BR>
Attention: Mark Kelson

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If to the Purchaser:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WOORI INVESTMENT &#038; SECURITIES<BR>
23-4 Yoido-dong Youngdungpo-gu Seoul 150-725 Korea

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Governing Law</U>. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware. No party shall have the right to assign any of
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">its rights or obligations under this Agreement without, in the case of the Purchaser, the
prior written consent of the Company, and in the case of the Company, the Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Jurisdiction; Venue</U>. With respect to any disputes arising out of or related to
this Agreement, the parties consent to the exclusive jurisdiction of, and venue in, the state
courts in Los Angeles County in the State of California (or in the event of exclusive federal
jurisdiction, the courts of the Central District of California).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Waiver of Jury Trial</U>. The Company and the Purchaser hereby irrevocably waive, to
the fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>California Corporate Securities Law</U>. THE SALE OF THE SECURITIES THAT ARE THE
SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE
OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE
CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS
EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE.
THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING
OBTAINED, UNLESS THE SALE IS SO EXEMPT.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors. Nothing in this
Agreement is intended or shall be construed to give any other person any legal or equitable right,
remedy or claim under or in respect of this Agreement or any provision contained herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Survival</U>. The respective representations, warranties and agreements of the Company
and the Purchasers contained in this Agreement shall survive the delivery of and payment for the
Shares and shall remain in full force and effect, regardless of any investigation made by or on
behalf of the Company or the Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Entire Agreement</U>. This Agreement, the Rights Agreement, the Lock-Up Agreement and
the Confidentiality Agreement constitute the full and entire understanding and agreement between
the parties with regard to the specific subject matter hereof, and any and all other written or
oral agreements relating to the specific subject matter hereof existing between the parties hereto
are expressly cancelled.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <U>Counterparts</U>. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <U>Amendments or Waivers</U>. No amendment or waiver of any provision of this Agreement,
nor any consent or approval to any departure therefrom, shall in any event be effective unless the
same shall be in writing and signed by the parties hereto.
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <U>Headings</U>. The headings herein are included for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
<BR>
HANMI FINANCIAL CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Jay S. Yoo
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Jay S. Yoo&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>CONFIDENTIAL</B>
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">Accepted: June 27, 2011&nbsp;</TD>
    <TD colspan="3" align="left">WOORI INVESTMENT &#038; SECURITIES<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Sung Ho Hwang
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Sung Ho Hwang,&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><I>&#091;Signature Page to Hanmi Financial Corporation Common Stock Purchase Agreement&#093;</I>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v59803exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;99.1</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>HANMI FINANCIAL CORPORATION<BR>
CONTACT INFORMATION:</B><BR>
David Yang &#151; (213)&nbsp;637-4798<BR>
<U>www.hanmibank.com</U>

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Hanmi Financial Corporation Announces Private Placement of Common Stock<BR>
To Woori Investment &#038; Securities</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">LOS ANGELES, June&nbsp;27, 2011 (GLOBE NEWSWIRE) &#151; Hanmi Financial Corporation (the &#147;Company&#148;) (Nasdaq:
HAFC), the parent company of its wholly&#151;owned subsidiary Hanmi Bank, today announced that it has
entered into a Common Stock Purchase Agreement for a private placement transaction to issue shares of the Company&#146;s common stock to Woori
Investment &#038; Securities (&#147;Woori&#148;). Pursuant to the terms of the Common Stock Purchase Agreement
dated June&nbsp;27, 2011, between Woori and the Company, Woori will be purchasing that number of shares
equal to 4.9&nbsp;percent of the Company&#146;s outstanding common stock immediately after the closing of the
Company&#146;s previously announced public offering, subject to adjustment in certain circumstances, at
a price per share equal to the public offering price. The private placement is contingent upon the
closing of the Company&#146;s public offering. The total amount
of common stock being sold in the private placement and the
Company&#146;s public offering is expected to total $75,000,000,
assuming no exercise of the underwriter&#146;s over-allotment option.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Hanmi President and CEO J.S. Yoo stated, &#147;We are quite pleased that Woori has committed to invest
in Hanmi in a private transaction, which is a significant step in our collaborative relationship.
We believe that our partnership with Woori Finance Holdings Co. Ltd.,
which is one of Korea&#146;s largest financial institutions and the
parent company of Woori Investment &#038; Securities,
should benefit both parties in expanding our ongoing business relationship and help to build value
for our shareholders.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company intends to contribute a substantial portion of the net proceeds from the private
placement to Hanmi Bank as additional capital and to support future organic and acquisition driven
growth. The Company intends to retain the remaining net proceeds at the Company level for use as
working capital and other general corporate purposes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About Hanmi Financial Corporation</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Headquartered in Los Angeles, Hanmi Bank, a wholly-owned subsidiary of Hanmi Financial Corporation,
provides services to the multi-ethnic communities of California, with 27 full-service offices in
Los Angeles, Orange, San Bernardino, San Francisco, Santa Clara and San Diego counties, and a loan
production office in Washington State. Hanmi Bank specializes in commercial, SBA and trade finance
lending, and is a recognized community leader. Hanmi Bank&#146;s mission is to provide a full range of
quality products and premier services to its customers and to maximize shareholder value.

</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Forward-Looking Statements</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This news release contains forward-looking statements for which the Company claims the protection
of the safe harbor contained in the Private Securities and Litigation Reform Act of 1995. These
forward-looking statements are subject to risks and uncertainties. A number of factors, many of
which are beyond the Company&#146;s ability to control or predict, could cause future results to differ
materially from those contemplated by such forward-looking statements. The Company&#146;s Annual
Report on Form 10-K and other SEC filings discuss the most significant risk factors that may affect
its business, results of operations and financial condition. The Company undertakes no obligation
to revise or update publicly any forward-looking statements for any reason.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
